Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Angiotensinogen (AGT) iRNA compositions and methods of use thereof

US Patent 11015201 · Granted May 25, 2021

Estimated economic value: $77,156,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for silencing UGT1a1 gene expression2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and me2025
Coagulation factor V (F5) iRNA compositions and methods of use thereof2025
Cell death-inducing DFFA-like effector B (CIDEB) iRNA compositions and methods o2025
Ketohexokinase (KHK) iRNA compositions and methods of use thereof2025
Coronavirus IRNA compositions and methods of use thereof2025
Complement component C3 iRNA compositions and methods of use thereof2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLK2025
Coagulation factor V (F5) iRNA compositions and methods of use thereof2025
Modified RNA agents with reduced off-target effect2025